“…30,39 Moreover, the association of cerulenin with Trastuzumab (Herceptin) synergistically enhances apoptotic cell death in a breast cancer cell line. 39 In addition, ErbB2 overexpressing NIH-3T3 cells show high FAS protein levels and cerulenin is able to inhibit their growth in soft agar as well as to induce enhanced apoptotic cell death, in comparison with the wild type cells. 31 In the last few years, FAS expression and activity have been described as abnormally high in several human cancers, 20,[22][23][24][25][26] including OSCC, [27][28][29] and associated with poor prognosis.…”